Is CBD safe for children?

GW Pharmaceuticals have achieved a Marketing Authorisation for a CBD based medicine to treat Dravets Syndrome, a rare and severe form of epilepsy. The clinical trial process for this authorisation will have included safety testing.  

However, this product is produced under strictly controlled conditions, to the medical highest standards of safety and consistency.  

No other CBD products have undergone this testing, and few are produced to GMP pharmaceutical standard.